Haemophilus
Haemophilus is a genus of small, Gram-negative bacteria that can cause various respiratory and invasive bacterial infections in humans. It commonly includes species such as Haemophilus influenzae, which can cause pneumonia, meningitis, otitis media and sinusitis. These bacteria are commonly found in the upper respiratory tract and may spread to other parts of the body. Certain strains, particularly type b (Hib), can cause severe infections, especially in young children. Treatment depends on the bacterial species, infection type and antibiotic susceptibility. Common symptoms of infection include fever, cough, sore throat, ear pain and breathing difficulties.
Haemophilus was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Haemophilus, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Haemophilus from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Haemophilus, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
